Heal Capital

Heal Capital is a Berlin-based venture fund dedicated exclusively to digital health, backed by a consortium of private health insurers in Germany and broader Europe. The fund’s structure is its most distinctive feature: rather than relying on traditional institutional LPs, Heal Capital draws capital from payers who have a direct strategic interest in funding the technologies that will reshape their cost structures and member experiences.

The thesis is concentrated on digital health, health IT and healthcare software, and diagnostics, with an explicit AI focus across those categories. The portfolio strategy is shaped by what the underlying insurer LPs want to see commercialized, which means digital therapeutics, care platforms, AI-enabled diagnostics, and software that improves clinical and administrative workflows are all in scope. The strategic alignment with payers gives Heal Capital a unique edge: portfolio companies often gain access to pilot programs, reimbursement pathways, and member populations that would be difficult to negotiate as a standalone startup.

The fund writes $1M to $5M checks at Seed and Series A, which positions it as an institutional lead or co-lead for the first or second professional round. Geographic focus is Germany and the broader DACH region, with European reach, and portfolio companies that succeed locally often expand across European markets where similar payer dynamics apply. Founders raising large Series B or growth rounds should look to other firms, while those at the formation stage may find Heal Capital writes earlier than its preferred band.

Team and specific partner names are not provided in the source data, and the LinkedIn listing is unconfirmed, so founders should engage through Heal Capital’s website. The team’s value sits in payer access as much as capital, and founders should expect diligence that probes whether the proposed product fits within reimbursable care pathways.

The approach is payer-aligned and reimbursement-aware. Heal Capital expects clarity on regulatory pathway, reimbursement strategy, and integration into existing care delivery before committing, which makes it a more demanding diligence partner than a generalist seed fund. The firm is a strong fit for digital health founders building products that pass through European payer systems and who can benefit from privileged insurer relationships. Pure consumer wellness plays without a clear clinical or reimbursement story will be a poor fit.